TY - JOUR
T1 - The Wnt antagonist, Dickkopf-1, as a target for the treatment of neurodegenerative disorders
AU - Caraci, Filippo
AU - Busceti, Carla
AU - Biagioni, Francesca
AU - Aronica, Eleonora
AU - Mastroiacovo, Federica
AU - Cappuccio, Irene
AU - Battaglia, Giuseppe
AU - Bruno, Valeria
AU - Caricasole, Andrea
AU - Copani, Agata
AU - Nicoletti, Ferdinando
PY - 2008
Y1 - 2008
N2 - The canonical Wnt pathway contributes to the regulation of neuronal survival and homeostasis in the CNS. Recent evidence suggests that an increased expression of Dickkopf-1 (Dkk-1), a secreted protein that negatively modulates the canonical Wnt pathway, is causally related to processes of neurodegeneration in a number of CNS disorders, including Alzheimer's disease (AD), brain ischemia and temporal lobe epilepsy (TLE). Dkk-1 induction precedes neuronal death in cellular and animal models of excitotoxicity, beta-amyloid toxicity, transient global ischemia, and kainate-induced epilepsy. In addition, Dkk-1, which is barely visible in the healthy brain, is strongly induced in brain tissue from AD patients or from patients with TLE associated with hippocampal sclerosis. These data raise the attractive possibility that Dkk-1 antagonists or neutralizing antibodies behave as neuroprotective agents by rescuing the activity of the canonical Wnt pathway
AB - The canonical Wnt pathway contributes to the regulation of neuronal survival and homeostasis in the CNS. Recent evidence suggests that an increased expression of Dickkopf-1 (Dkk-1), a secreted protein that negatively modulates the canonical Wnt pathway, is causally related to processes of neurodegeneration in a number of CNS disorders, including Alzheimer's disease (AD), brain ischemia and temporal lobe epilepsy (TLE). Dkk-1 induction precedes neuronal death in cellular and animal models of excitotoxicity, beta-amyloid toxicity, transient global ischemia, and kainate-induced epilepsy. In addition, Dkk-1, which is barely visible in the healthy brain, is strongly induced in brain tissue from AD patients or from patients with TLE associated with hippocampal sclerosis. These data raise the attractive possibility that Dkk-1 antagonists or neutralizing antibodies behave as neuroprotective agents by rescuing the activity of the canonical Wnt pathway
U2 - https://doi.org/10.1007/s11064-008-9710-0
DO - https://doi.org/10.1007/s11064-008-9710-0
M3 - Review article
C2 - 18427981
SN - 0364-3190
VL - 33
SP - 2401
EP - 2406
JO - Neurochemical research
JF - Neurochemical research
IS - 12
ER -